THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY patent applications published on March 21st, 2024
Summary of the patent applications from THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on March 21st, 2024
The organization (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY) has recently filed patents for innovative technologies in various fields:
- A system for implementing privacy-preserving smart contracts on a blockchain-based platform, ensuring confidentiality and anonymity while maintaining functionality with limited performance overhead. - A method and apparatus for scanning in a field of view using a pattern that improves sensing in a region of interest within the field of view. - Methods for treating subjects in need of IL-1 inhibitor therapy or IL-6 inhibitor therapy by determining the risk for drug-related hypersensitivity through HLA allele assays. - Methods and compositions for treating SCID-X1 in subjects by genetically modifying cells ex vivo with a full-length, codon-optimized IL2RG cDNA at the endogenous IL2RG locus.
Notable applications of these technologies include: - Secure financial transactions - Enhanced surveillance systems - Personalized medicine for tailored treatment plans - Gene therapy for genetic disorders
These innovations address critical issues in privacy, sensing capabilities, drug-related hypersensitivity, and genetic disorders, offering potential benefits such as increased privacy, improved data collection, enhanced patient safety, and targeted treatment options.
Contents
- 1 Patent applications for THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on March 21st, 2024
- 1.1 METHODS OF MODULATING NEURONAL AND OLIGODENDROCYTE SURVIVAL (18280126)
- 1.2 ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2 (18460452)
- 1.3 MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS (18363584)
- 1.4 CHEMICALLY REVERSIBLE 2`-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION (18377236)
- 1.5 GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS (18007439)
- 1.6 METHODS RELATING TO ANTI-IL-1 THERAPY AND ANTI-IL-6 THERAPY AND HYPERSENSITIVITY (18275474)
- 1.7 MULTIPLE-FREQUENCY-COMPONENT SCANNING INVOLVING SCAN-PATTERN DESIGN AND BALANCED OR OPTIMIZED ATTRIBUTES (18273735)
- 1.8 BLOCKCHAIN SYSTEM FOR CONFIDENTIAL AND ANONYMOUS SMART CONTRACTS (18515159)
Patent applications for THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on March 21st, 2024
METHODS OF MODULATING NEURONAL AND OLIGODENDROCYTE SURVIVAL (18280126)
Main Inventor
Shane LIDDELOW
ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2 (18460452)
Main Inventor
Kenan Christopher Garcia
MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS (18363584)
Main Inventor
Ravindra Majeti
CHEMICALLY REVERSIBLE 2`-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION (18377236)
Main Inventor
Linglan Fang
GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS (18007439)
Main Inventor
Mara Pavel-Dinu
METHODS RELATING TO ANTI-IL-1 THERAPY AND ANTI-IL-6 THERAPY AND HYPERSENSITIVITY (18275474)
Main Inventor
Vivian E. Saper
MULTIPLE-FREQUENCY-COMPONENT SCANNING INVOLVING SCAN-PATTERN DESIGN AND BALANCED OR OPTIMIZED ATTRIBUTES (18273735)
Main Inventor
Zhanghao Sun
BLOCKCHAIN SYSTEM FOR CONFIDENTIAL AND ANONYMOUS SMART CONTRACTS (18515159)
Main Inventor
Shashank Agrawal
